Altimmune (ALT)

Altimmune (ALT) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• ALT last traded at $2.04, -4.67% on the day.
• Altimmune: market cap $396.82M, P/E -2.6, revenue $41.00K over the last four quarters, next earnings 2026-11-05.
• Over the past year ALT returned -49.88%; year to date -43.49%.

Updated 2026-11-03 00:43 UTC